Aantal gebruikers 2018-2022 voor ATC-subgroep A10B : Bloedglucoseverlagende middelen excl. insulines
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| A10BA Biguaniden | 651.630 | 658.230 | 659.650 | 666.830 | 672.420 |
| A10BB Sulfonylureumderivaten | 304.010 | 308.320 | 311.110 | 320.220 | 325.010 |
| A10BD Combinaties van bloedglucoseverlagende middelen | 10.951 | 11.060 | 10.710 | 10.505 | 10.225 |
| A10BF Alfa-glucosidaseremmers | 1.400 | 1.235 | 900 | 780 | 782 |
| A10BG Thiazolidinedionen | 3.871 | 3.250 | 2.671 | 2.378 | 2.047 |
| A10BH Dipeptidylpeptidase-4-remmers | 38.148 | 44.219 | 46.885 | 48.884 | 47.838 |
| A10BJ Glucagonachtig peptide-1-agonisten (glp-1-agonisten) | 15.895 | 26.253 | 39.515 | 54.928 | 82.581 |
| A10BK Natriumglucose-cotransporter-2-remmers (sglt-2-remmers) | 15.443 | 16.887 | 19.946 | 39.715 | 113.180 |
| A10BX Overige bloedglucoseverlagende middelen excl. insulines | 697 | 700 | 703 | 660 | 612 |